The Opioid Epidemic and Child Welfare: Challenges and Responses

Many healthcare professionals do not fully appreciate the link between adverse child events, social determinants of health, and the incidence of opioid use disorders. Without attention to a systems of care foundation, treatment of opioid use disorders can be fragmented and not fully address multiple risk factors. Stakeholders have yet to fully shift paradigms from individual recovery to community and family-based systems of care.

Target Audience

This activity is designed for first responders, local Health Department Board of Health Members, local Health Department Staff, Public Health and Healthcare Students, and any other interested public health professionals.

Learning Objectives

Upon completion of this educational activity, you will be able to:

  • Discuss key data trends on how substance abuse effects child welfare
  • Describe concepts from successful programs that apply systems of care and harm reduction strategies
Course summary
Available credit: 
  • 0.75 Participation
    UK Healthcare CECentral certifies this activity for 0.75 hour(s) of participation.
Course opens: 
03/05/2024
Course expires: 
03/04/2027
Part of: 
2020 Kentucky Harm Reduction Summit
Rating: 
0

Faculty & Credentials

W David Lohr
W David Lohr, MD, DFAPA, DFAACAP
Professor Division of Child & Adolescent Psychiatry and Pediatric Psychology, Department of Pediatrics

University of Louisville School of Medicine,
Medical Director/Chief Medical Officer DCBS
 

 

Erin E. Smead
Erin E. Smead, MSW
Director, Kentucky Sobriety Treatment and Recovery Teams (START)
Kentucky Department for Community Based Services and
University of Kentucky College of Social Work
Lexington, Kentucky
 

 

Disclosure Information

No speakers, planners, or reviewers have any relevant financial relationships to disclose.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.


In support of improving patient care, this activity has been planned and implemented by University of Kentucky HealthCare CECentral and the Kentucky Department of Public Health. University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Available Credit

  • 0.75 Participation
    UK Healthcare CECentral certifies this activity for 0.75 hour(s) of participation.
Please login or register to take this course.